Silvia Taylor

Professional Overview

Silvia Taylor is a seasoned executive with extensive experience in corporate affairs, communications, and advocacy. As the Executive Vice President and Chief Corporate Affairs and Advocacy Officer at Novavax, she is responsible for leading the company's global corporate affairs strategy, external communication, and advocacy efforts, playing a critical role in advancing the organization's mission and impact within the biopharmaceutical industry.

Experience Summary

Current Role

In her current role at Novavax, Silvia is responsible for overseeing the company's corporate affairs, communications, and advocacy functions. She works closely with the leadership team to develop and execute strategic initiatives that enhance Novavax's reputation, visibility, and influence within the industry. Silvia's expertise in navigating complex regulatory environments and building effective stakeholder relationships has contributed to the company's ability to navigate challenges and capitalize on emerging opportunities.

Career Progression

Silvia's career trajectory has been marked by progressive growth and a diverse range of experiences. Prior to her current role, she served as the Executive Vice President and Chief Communications Officer at Novavax, where she led the company's global communications strategy and media relations. Before that, she held the position of Senior Vice President of Global Corporate Affairs and Investor Relations, where she played a crucial role in strengthening the company's corporate profile and investor engagement.

Silvia's experience extends beyond Novavax, as she has held senior leadership positions at other prominent biopharmaceutical and healthcare organizations, including Autolus Ltd., Sucampo Pharmaceuticals, Inc., and MedImmune. Throughout her career, she has demonstrated a track record of driving strategic communications, managing complex regulatory environments, and fostering strong relationships with key stakeholders, including government agencies, industry associations, and the investment community.

Academic Background

Silvia holds an MBA in Marketing and Management from Columbia Business School, where she honed her business acumen and strategic decision-making skills. She also earned a Bachelor of Arts degree in International Relations and Business from the University of Virginia, providing her with a well-rounded academic foundation and global perspective.

Areas of Expertise

Silvia's expertise spans several critical areas, including:

• Corporate affairs and strategic communications

• Regulatory and government affairs

• Stakeholder engagement and advocacy

• Investor relations and capital markets

• Crisis management and risk mitigation

• Strategic planning and execution

Professional Impact

Throughout her career, Silvia has made significant contributions to the organizations she has served. At Novavax, she has played a pivotal role in shaping the company's corporate strategy, enhancing its external visibility, and effectively navigating complex regulatory landscapes. Her leadership and strategic insights have been instrumental in positioning Novavax as a leading player in the biopharmaceutical industry.

Additionally, Silvia's commitment to industry associations is evidenced by her role as a member of the Board of Directors of the Maryland Technology Council, where she leverages her expertise to support the growth and development of the local technology ecosystem.

Conclusion

Silvia Taylor's extensive experience, strategic acumen, and proven track record of success make her a valuable asset to Novavax and the broader biopharmaceutical industry. As the Executive Vice President and Chief Corporate Affairs and Advocacy Officer, she is poised to continue driving the company's growth and impact, leveraging her expertise to navigate complex challenges and capitalize on emerging opportunities.